Synthes To Pay $23 Million For Illegal Testing, Marketing Scheme
This article was originally published in The Gray Sheet
Orthopedic device maker Synthes and its subsidiary Norian will pay a total of $23.2 million in criminal penalties for conducting unauthorized clinical trials of its Norian XR and Norian SRS bone cement products
You may also be interested in...
Product approvals from Boston Scientific, Bruker and Sorin. Bard completes drug-coated balloon PMA. HHS OIG amends Synthes corporate integrity agreement.
Federal authorities doled out prison time and fines to former executives of spinal fixation firm Synthes, and sent a broader warning to everyone in the industry about the penalties of corporate non-compliance for individuals.
Kensey Nash picks up Norian